Technical Analysis for ORTX - Orchard Therapeutics plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical ORTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | 1.31% | |
| Hammer Candlestick | Bullish | 1.31% | |
| Calm After Storm | Range Contraction | 1.31% | |
| Wide Bands | Range Expansion | 1.31% | |
| Gapped Down | Weakness | 1.31% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 20 DMA Resistance | about 15 hours ago | |
| 60 Minute Opening Range Breakout | about 16 hours ago | |
| Hammer Candlestick Entry | about 16 hours ago | |
| Rose Above Previous Day's High | about 16 hours ago | |
| Up 3% | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/22/2021
Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies. Orchard’s advanced portfolio of autologous ex vivo gene therapies targets serious and life-threatening rare diseases, initially primary immune deficiencies, neurometabolic disorders and hemoglobinopathies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Rare Diseases Nature Hemoglobin Immunodeficiency Metabolic Disorders Hemoglobinopathies Hemoglobinopathy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Rare Diseases Nature Hemoglobin Immunodeficiency Metabolic Disorders Hemoglobinopathies Hemoglobinopathy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.09 |
| 52 Week Low | 3.76 |
| Average Volume | 2,620,594 |
| 200-Day Moving Average | 5.81 |
| 50-Day Moving Average | 6.15 |
| 20-Day Moving Average | 7.13 |
| 10-Day Moving Average | 7.77 |
| Average True Range | 0.71 |
| ADX | 38.11 |
| +DI | 26.71 |
| -DI | 20.26 |
| Chandelier Exit (Long, 3 ATRs ) | 6.94 |
| Chandelier Exit (Short, 3 ATRs ) | 7.64 |
| Upper Bollinger Band | 9.09 |
| Lower Bollinger Band | 5.17 |
| Percent B (%b) | 0.45 |
| BandWidth | 54.97 |
| MACD Line | 0.37 |
| MACD Signal Line | 0.50 |
| MACD Histogram | -0.1351 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.39 | ||||
| Resistance 3 (R3) | 7.41 | 7.27 | 7.31 | ||
| Resistance 2 (R2) | 7.27 | 7.16 | 7.26 | 7.29 | |
| Resistance 1 (R1) | 7.11 | 7.09 | 7.04 | 7.09 | 7.26 |
| Pivot Point | 6.97 | 6.97 | 6.94 | 6.97 | 6.97 |
| Support 1 (S1) | 6.81 | 6.86 | 6.74 | 6.79 | 6.62 |
| Support 2 (S2) | 6.67 | 6.79 | 6.67 | 6.59 | |
| Support 3 (S3) | 6.51 | 6.67 | 6.57 | ||
| Support 4 (S4) | 6.49 |
